How UF Health Turns Genetics Into Actionable Info

How UF Health Turns Genetics Into Actionable Info

When a healthcare provider’s project transitions from research into clinical practice, it knows it has turned a corner. University of Florida Health turned that corner in June 2012 with a project that uses genetic testing to identify patients who can’t metabolize certain meds.

UF Health created a pilot program around patients entering its cardiac catheterization lab who are prescribed the blood thinner Plavix (clopidogrel). One in four patients can’t metabolize clopidogrel, which the lab prescribes to most entering patients.UF Health developed a test that identifies the gene responsible for clopidogrel metabolization and made the test a part of its standing orders.

Find out more about this at: http://www.informationweek.com/global-cio/interviews/how-uf-health-turns-genetics-into-action/240160901